Designing an AI Worker for Pharmaceutical Quality Events
A controlled pattern for collecting laboratory and production evidence while quality professionals retain impact, root-cause and CAPA decisions.
Intelliger Editorial Team•Jul 23, 2026Pharmaceutical quality events combine a large evidence burden with decisions that have material consequences. The same event may touch methods, instruments, samples, analysts, materials, environmental conditions and released product. A system that writes convincing prose without controlling those connections can increase risk rather than reduce it.
The useful AI pattern is a quality-event worker that prepares evidence and tests completeness. It does not replace the quality unit's authority.
Choose one event family
Do not begin with every deviation, out-of-specification result and complaint. Select one event family with a stable procedure and enough representative history. Define the opening signal, required evidence, decision stages and closure artefacts.
For a laboratory deviation, the first scope might cover instrument status, method version, sample handling, calculations, reference standards and analyst qualification. Product-impact and root-cause conclusions remain outside the worker's authority.
Preserve record context
An extracted value is not enough. The worker needs the record identifier, author, timestamp, version and relationship to the event. It must distinguish original data from a later correction and show whether a procedure was effective on the event date.
Useful controls include read-only access to authoritative systems, approved calculation services, immutable source links and a record of every tool call. Avoid copying uncontrolled document sets into a general-purpose workspace.
Make the investigation structure explicit
A review-ready case can contain:
- Event description and affected scope.
- Confirmed facts linked to original records.
- Required checks completed, failed or unavailable.
- Prior verified cases with relevant similarities and differences.
- Competing hypotheses and evidence needed to test them.
- Unresolved questions for the investigator and quality approver.
This structure prevents the narrative from getting ahead of the evidence.
Treat historical cases carefully
Past investigations can encode valuable expert judgement, but they are not automatically correct or current. Before reuse, verify the quality status, procedure context and final approval. Exclude cases with unresolved corrections or unreliable documentation.
When a historical pattern is surfaced, show why it is relevant. Matching instrument type alone may be weak. Matching method step, alarm sequence, sample handling and confirmed failure mechanism is stronger.
Test refusal and escalation
Evaluation must include cases where the worker should stop. Examples include missing original data, conflicting audit trails, an unidentified procedure version, potential data-integrity concerns, critical-product impact, a new failure mode or a requested action beyond the worker's mandate.
The handoff should state what was checked, what failed and which evidence is needed next. A generic "human review required" message is not enough.
Measure review readiness
Track time to complete evidence collection, missing-record detection, source-link accuracy, calculation accuracy, investigator rework and first-review acceptance. Record false reassurance as a distinct error category. A missed contradiction can be more serious than a slow case.
The pilot should run against representative historical cases before controlled live use. Version the worker's procedures, tools and evaluation suite together so a model or policy change cannot enter production without retesting.
The OATI Passport can carry assurance claims for the worker and its operator. The OATI Certified programme provides a path for conformance and assurance. These mechanisms support traceability, but the quality system still defines who may approve the event and under which procedure.